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Introduction
nature, they are not extracted by conventional methods and are generally isolated from vegetal aqueous extracts by fractionation on ion exchange column (Dräger, 2002) . The extraction protocol was based in the one described by Bekkouche et al. (2001) . Briefly, air-dried and powdered plant material was extracted three times by macerating in water/methanol (50/50, v/v) for 24 h. After centrifugation, the supernatant was evaporated to dryness and applied to a cation exchange column (Amberlite IR 120B, H+ form). The column 80 was washed with water to remove non-binding contaminants. Calystegines and bound compounds were eluted with 2 N NH4OH. The concentrated residue was then applied to an anion exchange column (Dowex 1 × 2, Cl− form) and eluted with water to obtain a purified plant extract that contains total calystegines.
Gas chromatography-mass spectrometry analysis 2.4.1. Derivatization
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In order to analyze calystegines by GC, a derivatization procedure was applied to form trimethylsilyl (TMS) ether derivatives. The different purified plant extracts were dissolved in pyridine (50 μl), mixed with 50 μl of trimethylsilyltrifluoroacetamide (MSTFA) and kept at 60 °C for 30 min; the reaction mixtures were then cooled and subjected to GC-MS analysis.
GC-MS procedure
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To characterize the calystegines of the different Hyoscyamus albus extracts, GC-MS was employed using the modified method of Bekkouche et al. (2001) . A GCMS-QP2010 plus system (Shimadzu, Kyoto, Japan) equipped with a DB-5 ms column (30 m × 0.25 mm I.D. × 0.25 μm df, Quadrex Corporation, Woodbridge, CT) was used. The separation was performed according to the following oven temperature program: initial temperature was 100 °C and held for 5 min, then it was raised to 300 °C at 10 °C/min, and this value was 95 maintained for 5 min. The injection volume was 0.5 μl in split mode (split ratio 1:10) with the injector temperature at 250 °C.
The carrier gas was He at 36.5 cm/s. The MS detection parameters were: interface temperature, 280 °C; Ion source temperature, 250 °C; mass range, m/z 50-600; scan speed, 2500 amu/seg; and event time, 0.20 seg. The data collection and handling were performed using the GCMS solution (ver. 2.50SU3, Shimadzu) 100 software.
Several ions were monitorized in SIM: 217 m/z was used as a common ion to monitor calystegines B 2 , B 3 , B 4 and C 1 ; 229m/z for monitoring calystegine B 2 ; 244 m/z for calystegine B 4 ; 189 m/z for calystegine B 1 , 156 m/z for calystegines A 3 and A 5 ; 375 m/z for calystegine C 1 ; and 390 m/z to monitor calystegine N 1 .
Antioxidant activity determination 105
DPPH radical scavenging assay
The DPPH radical scavenging activity was determined according to the method described by Lai et al. (2009) . Briefly, 1 ml of 0.1 mmol/l DPPH radical solution was mixed with 3 ml of various concentrations of extracts dissolved in methanol. The mixture was then vortexed vigorously and was incubated for 30 min in the dark at room temperature. For the control, 3 ml of methanol was used. The absorbance was measured at 110 517 nm. BHA and BHT, two well-known antioxidants, were used as references. All measurements were done in triplicate. The DPPH radical-scavenging activity was calculated as follows:
(1)Radical-scavenging activity (%) = (A C − A S /A C ) × 100 Where A C and A S are respectively the control and the sample absorbance.
TEAC assay
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The antioxidant activity of Hyoscyamus albus extracts was determined using the Trolox Equivalents Antioxidant Capacity (TEAC) assay (Re et al., 1999) . The ABTS
•+ radical cation was produced by reacting 7 mM ABTS and 2.45 mM potassium persulfate in the dark at room temperature for 16 h before use. After addition of 100 μL of samples to 1900 μL of diluted ABTS
•+ solution the absorbance reading was taken 7 min after at 734 nm. Trolox was used as the reference standard and the results were expressed as TEAC 120 values (mmol trolox/g of extract).
Reducing power assay
The reducing power was determined according to the method of Oyaizu (1986). Various concentrations of H. albus extracts (2.5 ml) were mixed with 2.5 ml of 200 mmol/l sodium phosphate buffer (pH 6.6) and 2.5 ml of 1% potassium ferricyanide. The mixture was incubated at 50 °C for 20 min, then 2.5 ml of 10% 125 trichloroacetic acid (w/v) were added, and the mixture was centrifuged at 650 rpm for 10 min. The upper layer (5 ml) was mixed with 5 ml deionized water and 1 ml of 0.1% of ferric chloride, and the absorbance was measured at 700 nm (higher absorbance indicates higher reducing power). The assays were carried out in triplicate and the results were expressed as mean values ± standard deviations. Trolox was tested in the same conditions at different concentrations in order to calculate TEAC values for tested extracts and results
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were expressed as mmol trolox/g extract.
In-vitro assay for inhibition of human erythrocyte hemolysis mediated by peroxyl free radicals
The in-vitro inhibition of human erythrocyte hemolysis by H. albus extracts was evaluated according to the procedures described by Yuan et al. (2005) . The human erythrocyte hemolysis was performed by the thermolabile azo-compound AAPH as the free radical initiator. A volume of 100 μl of 5% (v/v) suspension 135 of erythrocytes in PBS was added to 200 μl of 100 mmol/l AAPH solution (in PBS pH 7.4) and 100 μl of the three extracts with different concentrations. The reaction mixture was shaken gently while being incubated at 37 °C for 3 h. After that, the reaction mixture was diluted with 8 ml of PBS and centrifuged at 2000g for 10 min. The absorbance (A) of the resulting supernatant was measured at 540 nm by a spectrophotometer. Likewise, the reaction mixture was treated with 8 ml of distilled water to obtain a complete hemolysis (B).
140
The absorbance of it supernatant (B) was measured at the same condition. The inhibitive ratio (%) was calculated using the following formula:
2.6. Anti-inflammatory activity 2.6.1. Animals
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Eight groups of six adult male SWISS Albino mice (20-25 g) were purchased from Pasteur Institute in Algeria and used for the experiment. They were housed in acrylfiber cages (48 cm × 35 cm × 22 cm) at a controlled room (temperature 25 ± 3 °C and humidity 50 ± 10%) and were kept on a 12 h light: 12 h dark cycle. They were fed with standard diet and water ad libitum and acclimated 10 days before they were used and fasted for 12 h before testing. All experiments were approved by the Animal Ethics Committee of the University of Bejaia (Algeria) and conducted in strict compliance with internationally accepted principles 
Experimental procedure
Paw edema was induced by injecting 0.05 ml of 1% carrageenan in physiological saline into the subplantar 155 tissues of the right hind paw of each mouse. The extracts (100 and 200 mg/kg) were administered orally 60 min prior to carrageenan injection. The paw edema was measured (mm) before and then at 1, 2, 3, 4 and 5 h, after carrageenan injection. Mean values of treated groups were compared with mean values of a control group. Indomethacin (20 mg/kg) was used as the reference drug (Winter et al., 1962) . The percentage inhibition for each mouse and each group was obtained as follows:
Results
Characterization results
Leaves, flowers and seeds extracts of Hyoscyamus albus were analyzed to identify the present calystegines by GC-MS (Fig. 1) . Their retention indexes and MS fragmentation pattern were used for identification, Table 1 . GC-MS analysis of H. albus extracts showed that seeds extract contains most kinds of calystegines in highest amounts in comparison with leaves and flowers extracts. Calystegines A5, and N1 are the two common alkaloids in the three extracts with a maximum concentration of 180.22 ± 10.9 μg Calystegine N1/g DW in seeds and 117.36 ± 5.18 μg calystegine A5/g DW found in leaves. The characterization allowed the identification of calystegine B4 for the first time in this plant, and, as shown in Table 1 , this alkaloid is 170 present in highest proportion in seeds. It is also present in flowers but at less concentration. respectively, while leaves and flowers extracts gave only 65.89% and 70.37% DPPH inhibition and 9.71% and 17.75% ABTS inhibition at the same concentrations. This high activity could be related with the high amount of calystegines present in extracts. 
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The EC 50 corresponds to the concentration able to inhibit 50% of DPPH free radical, and TEAC indicates the TROLOX quantity that exercises the same activity of 1 mM of extract. In this way, seeds extract showed the highest antioxidant activity, that means the lowest EC 50 and the highest TEAC values (60.83 μg/ml and 111.4 μmol Trolox/g extract respectively). In contrast, leaves and flowers extracts had lower activities with an EC 50 of 196.55 and 190.22 μg/ml and TEAC of 38.33 and 82.03 μmol TROLOX/g extract respectively).
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Common used antioxidants, BHA and BHT, were employed as reference compounds showing the following antioxidant activities: EC50 = 0.97 and 3.89 μg/ml; TEAC = 6130 and 5950 μmol TROLOX/g compound for BHA and BHT respectively.
Reducing power
The reducing power was the second antioxidant activity measurement assay tested with H. albus seeds, 205 flowers and leaves. Fig. 3 represents the reducing power of H. albus extracts as absorbance versus concentrations, and Table 2 shows TEAC values of the different extracts and Ascorbic acid used as reference compound. Fe3+/ferricyanide complex reduction ability of Hyoscyamus albus extracts was concentration dependent with a maximum absorbance of 0.495, 1.186 and 1.475 AU for leaves, flowers and seeds extracts respectively at 5 mg/ml. TEAC values indicated that seeds extract has better activity (178.6 210 μmol Trolox/g extract) with only small difference compared to flowers extract (145.70 μmol Trolox/g extract). Results showed also that leaves exerted the lowest ferric reduction capacity (49 μmol Trolox/g extract).
In-vivo edema inhibition of Hyoscyamus albus antioxidant extracts rich in calystegines Lynda Bourebaba, Giuseppe Sullini, Jose A. Mendiola, Yasmina Bourebaba, Amirouche Deghima, Naima Oukil, Flowers. 145, 70 Seeds.
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In-vitro inhibition of human erythrocyte hemolysis
Hyoscyamus albus extracts were investigated for their capacity to protect normal Human erythrocytes against In-vitro hemolysis caused by aqueous peroxyl radicals, Fig. 4 shows the inhibitory effect of different 220 concentrations of extracts on an AAPH-induced hemolysis of 5% (v/v) Human erythrocytes for 3 h. Human erythrocytes hemolysis inhibition by calystegines was dose dependant, especially for seeds extract, that showed the highest activity against thermostable peroxyl radicals with a maximum of 54.03% hemolysis inhibition at 2.5 mg/ml. Leaves and flowers extracts presented more or less a similar effect much lower than that of seeds (22.6 and 28.03% hemolysis inhibition at the same concentration). 
In-vivo anti-inflammatory activity
Mice hind paw edema was induced by a sub-plantard injection of carrageenan salin solution; this caused an increase of foot pad circumference of group control up to 1.78 ± 0.26 mm at 4 h post-phlogistic agent 230 injection (Table. 3). In general, H. albus extracts showed potent and fast in-vivo anti-inflammatory effect with inhibition rates ranging from 21.3% to 58.33%. All samples acted at the 2nd hour of carrageenan injection unlike the standard that acted at the 3rd hour with an inhibition of 63.98%. Seeds and flowers were most active at 200 mg/kg with predominance of seeds extract which showed paw edema inhibition at 58.33%, 54.81% for flowers and only 30.75% for leaves extract rich in calystegines. 
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Discussion
In this study, Leaves, Flowers and Seeds of Hyoscyamus albus (Solanaceae) were investigated for their calystegines content, antioxidant and in-vivo anti-inflammatory activities. More than 14 different 240 calystegine structures have been published and most of them have been isolated from Solanaceae (Keiner and Dräger, 2000) . Calystegines of A, B and N group were found in Hyoscyamus albus extracts; according to literature, we have identified calystegines A3, A5, A5 glycoside, B1, B2, B4 and N1 in seeds extract, the same calystegines with less amounts in flowers and only calystegines A3 and N1 in leaves extract. Dräger et al. (1994) indicated that calystegines occur not only in the roots of Solanaceae plants but also in the leaves 245 and found that in Hyoscyamus albus the content of calystegines of the B-group is even higher. In the present study it was demonstrated that H. albus seeds and flowers are even richer in calystegines than leaves. The presence of A3, N1 and other calystegines of the B-group in leaves of Hyoscyamus albus L. has already been previously reported (Bekkouche et al., 2001) . In this study, occurrence of calystegine B4 in this species has been demonstrated for the first time.
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Hyoscyamus albus calystegines showed potent antioxidant activity, and due to their high degree of hydroxylated substitutions, the high antioxidant potential could be related to their several OH-moieties. In fact, Asano et al. (1997) demonstrated that an increase in degree of hydroxylation of the nortropane ring results in enhanced of biological activities of calystegines, which could explain the differences in efficiency observed between the different extracts. In all tests, seeds extract was most active. GC-MS analysis allowed 255 us to determine the presence of several calystegines in the three extracts, and indicated a highest content of calystegine B4 in seeds, a lower concentration in flowers and absence of this compound in leaves. The highest degree of hydroxylated pattern of this compound (4-OH) and the specific position of these substituents could explain the highest antioxidant efficiency of seeds extract.
Two main mechanisms by which antioxidants can play their protective role have been proposed. In the first 260 one, the free radical removes a hydrogen atom from the antioxidant that itself becomes a radical, this mechanism is referred to as H-atom transfer. A higher stability of the radical ArO corresponds to a better efficiency of the antioxidant ArOH, so that it is unlikely to react with the substrate (Leopoldini et al., 2011) . In this mechanism, the bond dissociation enthalpy (BDE) of the O H bonds is an important parameter in the evaluation of the antioxidant action, because the weaker the OH bond the easier will be the reaction of free 265 radical inactivation.
In the second mechanism (the one-electron transfer), the antioxidant can give an electron to the free radical becoming itself a radical cation. Also in this case, the radical cation arising from the electron transfer must be stable, so it does not react with substrate molecules (Leopoldini et al., 2011) . Some studies provide important information on the structure-activity relationship of the antioxidants and stressed the importance of the ortho-hydroxyl and ortho-electron donating groups (possibly para-as well) that exhibit pronounced antioxidant activity (Lee et al., 2015; Murias et al., 2005) In this study and based on the common uses of Hyoscyamus albus in folk medicine, an In-vivo model of acute inflammation (mice paw edema induced by the injuring agent carrageenan) was used to investigate the supposed anti-inflammatory effect of H. albus calystegines. This experiment is a widely used model to test 275 new anti-inflammatory drugs and is generally used to evaluate the anti-edematous effect of natural products (Buapool et al., 2013) . As shown in results section, H. albus extracts demonstrated potent anti-inflammatory effect for the three different parts tested, and seems that they play their action at the 2nd hour of edema induction.
Carrageenan-induced edema causes the release of several inflammatory mediators such as histamine, 280 serotonin, bradykinin and prostaglandins. The development of an edema induced by carrageenan is a three phase event; the first occurring between 0 and 1.5 h after injection, is caused by the release of histamine and serotonin, the second is mediated by bradykinin after 1.5-2.5 h and finally, the third phase, after 2.5-6 h, has been correlated with an increased production of prostaglandins (Buapool et al., 2013) . Local and/or systemic inflammation is associated with enhanced levels of the pro-inflammatory cytokines TNF-α, IL-1, and IL-6 285 (Cuzzocrea et al., 1999) . The initial phase of edema, which is not inhibited by nonsteroidal antiinflammatory drugs (NSAIDs) such as indomethacin or aspirin but in this case inhibited by H. albus calystegines, has been attributed to the release of histamine, 5-hydroxytryptamine (5-HT) and bradykinin. The second accelerating phase of swelling has not only been correlated with the elevated production of prostaglandins, but more recently has been attributed to the induction of inducible cyclooxygenase (COX-2) 290 in the hind paw (Nantel et al., 1999) .
The anti-inflammatory effect of calystegines can occur via several mechanisms prominent of which is inhibition of pro-inflammatory cytokine-dependent up-regulation of adhesion molecule expression (Kelly and Whe, 1994) . Since histamine mediates the early stages of vasodilation and increased vascular permeability which characterize the acute inflammatory response, it has been established that leukocytes and 295 platellets are largely implicated in histamine release during this process (Chacko et al., 2011) . Leukocytes recruitment in acute and chronic inflammation is characterized by sequential cell adhesion and activation events. Migration processes of these cells recruit granulocytes, including polymorphonuclear leukocytes in particular but also monocytes and dendritic cells, to acute inflammatory sites. The selectins that are implicated in leukocytes migration and recruitment to vascular endothelium are type I membrane-spanning 300 glycoproteins. Expression of some of them (as E-selectin) is largely confirmed; where it is induced via transcription-dependent mechanisms directed by interleukin (IL)-1b, tumor necrosis factor alpha (TNF-α) and other inflammatory mediators. Cell adhesion interactions involved the presence of specific counterreceptors with specific glycan-based post-translational modification, which is the consequence of a series of ordered glycosyltransferase dependent events characterized by glycan polymer elongation or branching 
Conclusions
The presence of several calystegines in leaves, flowers and seeds of Hyoscyamus albus has been demonstrated by means of GC-MS; furthermore, the occurrence of calystegines A 5 and B 4 has been shown for the first time in this plant. Moreover, antioxidant activity of seeds, flowers and leaves extracts has been tested by different methods, being seeds extract which had the strongest activity, which can be related with 315 the highest content of calystegines compared to leaves and flowers. Similar trend was found in antiinflammatory test, where H. albus extracts showed strong activity, being seeds extract the strongest.
